Levetiracetam-Mepha 500 mg/5 ml
Levetiracetam-Mepha 500 mg/5 ml is a medicine authorised by Swissmedic under authorisation number 62615. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 08 April 2013 and the authorisation is valid without a time limit. ATC code N03AX14 places the medicine in the group Antiepileptics.
| Authorisation number | 62615 |
|---|---|
| Name | Levetiracetam-Mepha 500 mg/5 ml |
| Full name | Levetiracetam-Mepha 500 mg/5 ml, Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N03AX14 |
| First authorisation | 08 April 2013 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Levetiracetam-Mepha 500 mg/5 ml, Konzentrat zur Herstellung einer Infusionslösung | B | 08 April 2013 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | N03AX14 | 01.07.1. | B |
| 2 | 10 | Durchstechflasche(n) | N03AX14 | 01.07.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Levetiracetam-Mepha 500 mg/5 ml authorised in Switzerland?
Yes. Levetiracetam-Mepha 500 mg/5 ml is authorised by Swissmedic under authorisation number 62615, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Levetiracetam-Mepha 500 mg/5 ml have?
Levetiracetam-Mepha 500 mg/5 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Levetiracetam-Mepha 500 mg/5 ml?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.